Minimal Stimulation or Clomiphene Citrate as First Line Therapy in Women With Polycystic Ovary Syndrome
All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5
days starting from day 3 of spontaneous or induced menstruation. In group A (minimal
stimulation), 2 vials of highly purified uFSH , 150 IU (Fostimon; IBSA, Lugano, Switzerland,
75 IU/vial) were given IM on cycle day 9. A total of 3 cycles was offered to each group.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
clinical pregnancy rate per cycle
No
Hatem Abu Hashim, MD MRCOG
Principal Investigator
Mansoura University Hospitals
Egypt: Institutional Review Board
MU-290s
NCT01157312
August 2008
April 2010
Name | Location |
---|